UNITED THERAPEUTICS Corp
UTHRNasdaqCIK 1082554HealthcareFiscal year ends Dec 31
All transactions: 65
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 80 | $566.43 | $45.3k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 480 | $565.355 | $271.4k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 768 | $564.6309 | $433.6k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 1,253 | $563.4252 | $706.0k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 960 | $562.5403 | $540.0k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 200 | $561.4429 | $112.3k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 820 | $560.4954 | $459.6k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 743 | $559.2482 | $415.5k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 1,137 | $558.3184 | $634.8k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 1,702 | $557.2454 | $948.4k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 567 | $556.4129 | $315.5k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 550 | $555.1946 | $305.4k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 194 | $553.7824 | $107.4k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Sale | 46 | $552.5241 | $25.4k | Form 4 |
| 2026-10-21 | Rothblatt Martine aChairperson & CEO, Director, Officer | Option exercise | 9,500 | $117.76 | $1.1m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 13, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.